Evans Syndrome Overview

Save information for later
Sign Up

Learn About Evans Syndrome

What is the definition of Evans Syndrome?
Evans syndrome is a very rare autoimmune disorder in which the immune system destroys the body's red blood cells, white blood cells and/or platelets. Affected people often experience thrombocytopenia (too few platelets) and Coombs' positive hemolytic anemia (premature destruction of red blood cells). Signs and symptoms may include purpura, paleness, fatigue, and light-headedness. The exact cause of this condition is unknown.
What are the alternative names for Evans Syndrome?
  • Evans syndrome
  • Autoimmune hemolytic anemia and autoimmune thrombocytopenia
  • Evan syndrome
Who are the top Evans Syndrome Local Doctors?
Elite in Evans Syndrome
Bruno Fattizzo
Elite in Evans Syndrome
Bruno Fattizzo
Milan, IT 

Bruno Fattizzo practices in Milan, Italy. Fattizzo and is rated as an Elite expert by MediFind in the treatment of Evans Syndrome. His top areas of expertise are Autoimmune Hemolytic Anemia, Anemia, Evans Syndrome, Splenectomy, and Bone Marrow Transplant.

Elite in Evans Syndrome
Nathalie Aladjidi
Elite in Evans Syndrome
Nathalie Aladjidi
Bordeaux, FR 

Nathalie Aladjidi practices in Bordeaux, France. Aladjidi and is rated as an Elite expert by MediFind in the treatment of Evans Syndrome. Her top areas of expertise are Evans Syndrome, Autoimmune Hemolytic Anemia, Purpura, Immune Thrombocytopenic Purpura (ITP), and Splenectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Evans Syndrome
Guy G. Leverger
Elite in Evans Syndrome
Guy G. Leverger
Paris, FR 

Guy Leverger practices in Paris, France. Leverger and is rated as an Elite expert by MediFind in the treatment of Evans Syndrome. His top areas of expertise are Evans Syndrome, Autoimmune Hemolytic Anemia, Childhood Acute Myeloid Leukemia, Splenectomy, and Bone Marrow Transplant.

View All Doctors
What are the latest Evans Syndrome Clinical Trials?
A Prospective, One-arm and Open Clinical Study to Assess Safety and Efficacy of Anti-CD38 Antibody in the Treatment of Evans Syndrome
A Prospective, One-arm and Open Clinical Study to Assess Safety and Efficacy of Anti-CD38 Antibody in the Treatment of Evans Syndrome
Enrollment Status: Recruiting
Publish Date: February 21, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: A single-center, open-label, off-label use investigator-initiated clinical study with safety run-in to explore the clinical activity and safety of Anti-CD38 Antibody in adult ES patients who have not responded adequately or relapsed after first-line treatment and at least one second-line therapy including immunosuppressive agents, Anti-CD20 Antibody and/or TPO-RA, or those in whom no other second-...

Match to trials
Find the right clinical trials for you in under a minute
Get started
French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia (OBS'CEREVANCE Cohort)
French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia (OBS'CEREVANCE Cohort)
Enrollment Status: Recruiting
Publish Date: July 10, 2023
Intervention Type: Other

Summary: From 2004, OBS'CEREVANCE is a national real-world prospective clinical cohort of patients with auto-immune cytopenia of pediatric-onset : Immune thrombocytopenia (ITP), Autoimmune Hemolytic anemia (AIHA), or Evans syndrome (all bi or tri cytopenias). Thanks to the collaboration of the 30 French pediatric hematologic centers, this cohort supports all of the Rare Disease Centre CEREVANCE (Centre de ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center